Summarizing the Interventional Meibomian Gland Dysfunction (MGD) Consensus Findings: Part 2 episode artwork

EPISODE · Mar 15, 2023 · 20 MIN

Summarizing the Interventional Meibomian Gland Dysfunction (MGD) Consensus Findings: Part 2

from Eyecare Innovations Today: An Ophthalmic Educational Podcast Series · host Evolve Medical Education, LLC and The Fundingsland Group

In this episode, Drs. Ayres and Gupta discuss findings from the Interventional Meibomian Gland Dysfunction (MGD) Consensus, namely those related to the use of modern interventional MGD treatments. Faculty review various palliative and prescription-based MGD treatment options and discuss how interventional MGD treatments differ from more conventional treatments and how patient education is important when incorporating interventional MGD treatments into a standard clinical practice. This independent educational activity is supported by unrestricted educational grants from Alcon, Johnson & Johnson Vision, and Sight Sciences.

Episode metadata supplied by the publisher feed · Published Mar 15, 2023

Embed this episode

NOW PLAYING

Summarizing the Interventional Meibomian Gland Dysfunction (MGD) Consensus Findings: Part 2

0:00 20:56

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Eyecare Innovations Today: An Ophthalmic Educational Podcast Series?

This episode is 20 minutes long.

When was this Eyecare Innovations Today: An Ophthalmic Educational Podcast Series episode published?

This episode was published on March 15, 2023.

Can I download this Eyecare Innovations Today: An Ophthalmic Educational Podcast Series episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!